HKSE · 2877.HK
China Shineway Pharmaceutical Group Limited
HK$7.51+HK$0.23 (+3.09%)
China Shineway Pharmaceutical Group Limited’s quoted price sits in the lower half of its reported 52-week range, 28.32% below the high.
Loading market information…
OTC · TRXDW · USD
Stock price
Quote as of Sep 18, 2024, 07:24 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Asensus Surgical, Inc. is a medical technology firm dedicated to the innovation, development, and commercialization of robotic surgical systems aimed at enhancing minimally invasive procedures. The company’s global reach extends across the United States, Europe, the Middle East, Africa, and Asia. It distinguishes itself by digitizing the crucial interface between the surgeon and the patient, enabling a form of "performance-guided surgery" designed to optimize patient outcomes. The company’s product portfolio includes the Senhance System, a sophisticated multi-port robotic platform allowing surgeons to control up to four robotic arms, instruments, and a camera for laparoscopic operations. It also offers a range of specialized surgical instruments, such as 3mm diameter instruments, 3mm and 5mm hooks, and articulating tools. Furthermore, the Senhance ultrasonic system provides an advanced energy solution for the controlled ligation and division of tissue. Originally known as TransEnterix, Inc., the company officially changed its name to Asensus Surgical, Inc. in February 2021. Its corporate headquarters are located in Durham, North Carolina.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:50 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
THE ANALYST VIEW
6 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$7.51+HK$0.23 (+3.09%)
China Shineway Pharmaceutical Group Limited’s quoted price sits in the lower half of its reported 52-week range, 28.32% below the high.
$0.82$0.00 (0.0%)
Medivir AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 8.89% below the high.
$1.00$0.00 (0.0%)
Assisted 4 Living, Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
$0.03$0.00 (0.0%)
Abliva AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 25.13% below the high.
$4.08$0.00 (0.0%)
Relief Therapeutics Holding AG’s quoted price sits in the lower half of its reported 52-week range, 73.06% below the high.
$1.96+$0.00 (0.0%)
MedPeer,Inc.’s quoted price sits in the lower half of its reported 52-week range, 100.0% below the high.
$0.11-$0.01 (-9.69%)
Small Pharma Inc.’s quoted price sits in the lower half of its reported 52-week range, 41.36% below the high.
$0.70-$0.00 (-0.16%)
Enzo Biochem, Inc.’s quoted price sits in the lower half of its reported 52-week range, 41.27% below the high.
